By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast Page 53
NEW YORK (Reuters Health) – To combat psoriasis, a combination of topical therapies seems to work better than topical monotherapy, according to results of a systematic review and…
NEW YORK (Reuters Health) – Antibiotic prophylaxis with cefazolin during elective cesarean delivery, administered either before skin incision or after umbilical cord clamping, reduced postoperative maternal infections by…
NEW YORK (Reuters Health) – Tonsillectomy is an effective treatment for children with dysphagia related to enlarged tonsils, according to results of a prospective cohort study. Removing the…
NEW YORK (Reuters Health) Results of a retrospective study confirm that the Rule of 7’s prediction tool accurately identifies children who are unlikely to have Lyme meningitis, investigators…
NEW YORK (Reuters Health) Treatment with macrolide antibiotics appears to reduce mortality among patients with acute lung injury, according to a secondary analysis of data from a clinical…
NEW YORK (Reuters Health) The first report of 10-year outcomes of hepatocellular carcinoma treated by percutaneous radio frequency ablation (RFA) indicates that about 1 in 4 patients survive…
NEW YORK (Reuters Health) – Vaginal progesterone given to pregnant women with mid-trimester sonographic evidence of short cervix reduces the risk of preterm birth and neonatal complications and…
NEW YORK (Reuters Health) Pooled data from four relatively small but high-quality prospective randomized controlled studies suggest an advantage to intracoronary (IC) over intravenous (IV) administration of abciximab…
NEW YORK (Reuters Health) Treatment for up to 24 months with fesoterodine (Toviaz; Pfizer Inc) may yield sustained improvement in bladder problems and health-related quality of life in…
NEW YORK (Reuters Health) – For women with breast cancer metastatic to bone, treatment with zoledronic acid to reduce skeletal complications does not prolong progression-free survival or overall…
